Users Online : 541 About us |  Subscribe |  e-Alerts  | Feedback | Login   |   
Journal of Minimal Access Surgery Current Issue | Archives | Ahead Of Print Journal of Minimal Access Surgery
           Print this page Email this page   Small font sizeDefault font sizeIncrease font size 
  Search
 
  
 ¤   Similar in PUBMED
 ¤  Search Pubmed for
 ¤  Search in Google Scholar for
 ¤Related articles
 ¤   Article in PDF (855 KB)
 ¤   Citation Manager
 ¤   Access Statistics
 ¤   Reader Comments
 ¤   Email Alert *
 ¤   Add to My List *
* Registration required (free)  


 ¤  Abstract
 ¤ Introduction
 ¤ Case Report
 ¤ Discussion
 ¤  References
 ¤  Article Figures

 Article Access Statistics
    Viewed992    
    Printed34    
    Emailed0    
    PDF Downloaded92    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents     
UNUSUAL CASE
Year : 2021  |  Volume : 17  |  Issue : 4  |  Page : 551-553
 

Gastric glomus tumour: A case report


1 Department of Surgery and Pathology, MGM Medical College and Hospital, Aurangabad, Maharashtra, India
2 Department of Pathology, MGM Medical College and Hospital, Aurangabad, Maharashtra, India

Date of Submission23-Nov-2020
Date of Acceptance27-Mar-2021
Date of Web Publication25-May-2021

Correspondence Address:
Dr. Akshi Gupta
Department of Pathology, MGM Medical College and Hospital, Aurangabad, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jmas.JMAS_299_20

Rights and Permissions

 ¤ Abstract 

Glomus tumours (GTs) are rare, mesenchymal neoplasms arising from the glomus body. Atypical sites, like the stomach, have been reported with extreme rarity since the usual location lies under the nail beds. We report a rare case of gastric GT in a 28-year-old female presenting with upper abdominal pain, intermittent haematemesis and melena. Contrast-enhanced computed tomography indicated a well-defined, heterogeneously enhancing lesion in the antral region of the stomach and a possibility of gastrointestinal (GI) stromal tumour (GIST). Upper GI endoscopy showed a wide-based lesion in the sub-mucosal plane with ulcerated mucosa. Laparoscopic excision of the tumour with primary closure of the defect was performed, with an uneventful post-operative course. Histopathological and immunohistochemical findings confirmed a gastric GT. Follow-up clinical and endoscopic examinations were normal. Gastric GTs should be a rare differential in patients with suspected GIST and upper GI bleed.


Keywords: Gastric glomus tumour, gastrointestinal stromal tumour, glomus body, immunohistochemistry


How to cite this article:
Tantia M, Suryawanshi PR, Gupta A, Rachakatla P. Gastric glomus tumour: A case report. J Min Access Surg 2021;17:551-3

How to cite this URL:
Tantia M, Suryawanshi PR, Gupta A, Rachakatla P. Gastric glomus tumour: A case report. J Min Access Surg [serial online] 2021 [cited 2021 Dec 5];17:551-3. Available from: https://www.journalofmas.com/text.asp?2021/17/4/551/316916



 ¤ Introduction Top


Glomus tumours (GTs) are rare, usually benign mesenchymal neoplasms arising from the normal glomus body. Usually found in the distal extremities, their occurrence in the gastrointestinal (GI) tract is extremely rare, accounting for <1% of all GI soft tissue tumours.[1] Owing to their sub-mucosal location, gastric GTs are often mistaken for gastrointestinal stromal tumour (GIST) and other gastric sub-mucosal neoplasms, making their diagnosis largely dependent upon pathological and immunohistochemical findings.[2]


 ¤ Case Report Top


A 28-year-old female presented to the general surgery outpatient department with complaints of upper abdominal pain for 1 month and intermittent haematemesis.

On examination, she had pallor and mild tenderness over the epigastric region, with no palpable mass in the abdomen.

Other than mild anaemia (haemoglobin – 10.1 g/dL), her laboratory investigations were normal. Contrast-enhanced computed tomography (CECT) of the abdomen showed a well-defined lesion measuring 37 mm × 33 mm in the antrum, with possibility of GIST. Upper GI endoscopy demonstrated a wide-based polypoid growth with ulcerated mucosa [Figure 1]. Diagnostic laparoscopy revealed a lesion approximately 3 cm proximal to the pylorus. A wide local resection was done, and the antral continuity restored by closing it transversely.

Histopathological examination revealed sheets and islands of small round tumour cells involving the mucosa and extending unto the serosa, with margins free for involvement [Figure 2]a. A differential diagnosis of well-differentiated neuroendocrine tumour, GT and GIST was given.
Figure 1: An endoscopic view of a polypoid growth in the greater curvature, with ulcerated surface

Click here to view
Figure 2: (a) Sheets and islands of small round cell tumour involving the sub-mucosa and muscularis propria and extending up to serosa. Plenty of blood vessels of variable size are seen interspersed within the tumour (H and E, ×20). (b) Tumour cells showing positive membrane staining for smooth muscle actin

Click here to view


Immunohistochemistry (IHC) for confirmation stained positive for smooth muscle actin (SMA), caldesmon-H and actin and negative for CD117, DOG1, CD34, pan CK, synaptophysin and chromogranin [Figure 2]b. The final diagnosis of gastric GT was provided.

The postoperative course was uneventful. A check endoscopy after 3 months showed no residual lesion or narrowing of the stomach. At 1 year of follow-up, the patient was asymptomatic.


 ¤ Discussion Top


The normal glomus body, typically located in the dermis of the skin, is a rich network of arteriovenous anastomoses and nerve fibres, which plays an important role in thermoregulation.

GTs are usually found in the sub-ungal region of the distal extremities however have been described in the GI tract as well. The antral portion of the stomach is the most frequent GI site affected, accounting for 2.2% of gastric sub-mucosal tumours.[1]

The first gastric GT was described in a 64-year-old man in 1928 by Talijeva, and since then, just over 200 cases have been reported in the literature.[2]

It is very difficult to diagnose gastric GT pre-operatively. The symptoms range from asymptomatic to abdominal pain, GI bleed (sometimes massive) and perforation. Imaging modalities like contrast enhanced computed tomography (CECT) scan and magnetic resonance imaging (MRI) can demonstrate the location of the lesion in the stomach with its relation to surrounding structures. These findings are nonspecific and may be seen in other mesenchymal or stromal lesions such as GIST, neuroendocrine tumours and schwannomas.

Endoscopic ultrasound (EUS) can accurately delineate the extent and invasion of GT and is particularly useful when EUS-guided fine-needle aspiration is done.[3]

Mostly diagnosed on histopathology, it is difficult to differentiate benign from malignant in GTs. Accordingly, Folpe et al. proposed criteria for malignancy include deep location, size >2 cm and combination of high nuclear grade and mitotic activity (>5/50 HPFs).[4]

IHC is necessary to accurately diagnose GTs. They demonstrate positive staining with vimentin, SMA and lack of staining with CD117. Our case also demonstrated similar staining patterns enabling us to provide a diagnosis of Gastric GT.

Wedge resection, with a clean margin, is the treatment of choice, and enucleation methods are associated with a high risk of recurrence. The location of the tumour greatly influences the surgical intervention required. In our case, the growth was 3–4 cm proximal to the pylorus, which enabled us to perform a wedge resection with transverse closure, without any lumen compromise. At times, the lesion may require a distal or subtotal gastrectomy with appropriate reconstruction.[5]

Gastric GTs carry a small risk of recurrence, mostly at the site of excision. Therefore, it is recommended to perform endoscopy annually on follow-up.

To conclude, gastric GTs are rare mesenchymal neoplasms, which are difficult to diagnose preoperatively, given their lack of any specific clinical or imaging finding. The histological examination and IHC markers play a vital role in establishing correct diagnosis and optimising the treatment.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the legal guardian has given his consent for images and other clinical information to be reported in the journal. The guardian understands that names and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
 ¤ References Top

1.
Fletcher CD, Hogendoorn P, Mertens F, Bridge J. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon, France; IARC Press; 2013. p. 116.  Back to cited text no. 1
    
2.
Xu XD, Lu XH, Ye GX, Hu XR. Immunohistochemical analysis and biological behavior of gastric glomus tumours: A case report and review of the literature. Int Med Res 2010;38:1539-46.  Back to cited text no. 2
    
3.
Debol SM, Stanley MW, Mallery S, Sawinski E, Bardales RH. Glomus tumor of the stomach: Cytologic diagnosis by endoscopic ultrasound-guided fine-needle aspiration. Diagn Cytopathol 2003;28:316-21.  Back to cited text no. 3
    
4.
Folpe AL, Fanburg-Smith JC, Miettinen M, Weiss SW. Atypical and malignant glomus tumors: Analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol 2001;25:1-2.  Back to cited text no. 4
    
5.
Park YS, Park SW, Kim TI, Song SY, Choi EH, Chung JB, et al. Endoscopic enucleation of upper-GI submucosal tumors by using an insulated-tip electrosurgical knife. Gastrointest Endosc 2004;59:409-15  Back to cited text no. 5
    


    Figures

  [Figure 1], [Figure 2]



 

Top
Print this article  Email this article
 

    

© 2004 Journal of Minimal Access Surgery
Published by Wolters Kluwer - Medknow
Online since 15th August '04